While we’ve yet to see exactly how fast the Bugatti Chiron is, the French marque went to extraordinary lengths during its development to ensure it could survive the most brutal abuse. At a recent ...
Not long after Bugatti's new Chiron set an official world record for the quickest time for a production car to accelerate to 400 kph and then brake back to a dead stop (41.96 seconds), another ...
Bugatti developed a special dynamometer just for its hypercars. The Bugatti Chiron is too fast and powerful for a regular dyno. Dynamometers are a huge part of the testing process for new cars as well ...
As if breaking the 300 miles-per-hour barrier in a pre-production road car wasn’t cool enough, Bugatti test driver Andy Wallace recently revealed that the Chiron he drove to 304.773 mph actually ...
If you're reading this site, you're likely familiar with the Bugatti Chiron. It's the ultra-powerful, ultra-expensive, top-shelf Bugatti — and one of the last of its kind, before the company merged ...
Fast Lane Only on MSN
Why the 2019 Bugatti Chiron Super Sport 300+ chased history
The 2019 Bugatti Chiron Super Sport 300+ was not built to shave a tenth off a lap time or to win a marketing slogan. It was ...
Remember the contraption you used when passing your driver's test? Well, the adventure we're here to showcase involves a 17-year-old who visited the DMV for the purpose mentioned above in a (drum ...
Chiron Corp. said yesterday it has received U.S. Food & Drug Administration approval to commercialize a new and more sensitive test to screen donated blood for HIV and hepatitis C. Chiron shares rose ...
Chiron Corp. and Gen-Probe Inc. said Tuesday that U.S. regulators had accepted their application to sell a blood test for West Nile virus, a potentially fatal mosquito-borne disease that infected ...
Bugatti has taken orders for 250 of its magnificent Chiron super sports car — half the run of 500 cars — all without giving customers a single test drive, the company announced today. Bugatti plans to ...
Shares in Chiron Corp. slid 9 percent yesterday after the Emeryville biotech company reported than an experimental medicine failed a final stage clinical trial. Before yesterday's announcement, Chiron ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results